PSA calls for timely implementation of real-time prescription monitoring in SA

Wednesday 26 June 2019

 

The recent South Australian Government Budget announcement to implement a real-time prescription monitoring system (RTPM) is a good step forward, but the Pharmaceutical Society of Australia (PSA) calls on the government to ensure it is given high priority.

 

PSA SA/NT Branch President Robyn Johns urged the SA Government to follow through on this Budget commitment to help improve the health of South Australians.

 

“Real-time prescription monitoring was included in the state’s 2018-19 Budget but as yet we haven’t seen any progress,” she said.

 

“The 2019-20 Budget commitment of $4 million dollars to implement the system is very promising. However, timely implementation is crucial.”

 

PSA’s Medicine Safety: Take Care report highlighted the severity and cost of medicine-related problems. They are responsible for 250,000 hospital admissions and 400,000 emergency department presentations in Australia each year, costing the healthcare system $1.4 billion annually. At least half of this harm is avoidable.

 

“Medicine safety is a health priority and implementation of an RTPM system in South Australia will aid clinical decision making and provide an opportunity to identify and appropriately manage patients misusing specific prescription medications. In turn, this will help address medicine-related harm and ensure optimal health outcomes for South Australians,” Ms Johns said.

 

The Budget announcement states the estimated completion date of the RTPM system implementation is June 2020. PSA stands ready to engage with the government to achieve implementation within this timeframe.

 

Although PSA supports the independent work of states and territories in implementing real-time prescription monitoring systems, PSA believes this will continue to pose significant risks around interoperability across jurisdictions.

 

PSA has long advocated for the immediate implementation of a national recording and reporting system which would enable real-time monitoring to address the increase in harm resulting from inappropriate use of certain prescription medicines.

 

In 2018 the Council of Australian Governments (COAG) agreed to progress a national solution where each jurisdiction develops their own system to connect with a Commonwealth system.

 

Some progress has been made with all states and territories, except NSW and WA, either implementing or setting strategies to introduce an RTPM system. Queensland is the most recent state to do so, introducing legislation into parliament in May that will enable the state’s health department to implement a mandatory RTPM system.

 

One of the key actions in PSA’s Pharmacists in 2023 report is to embrace digital transformation to improve the quality use of medicines; support the delivery of safe, effective, and efficient healthcare; and facilitate collaborative models of care.

 

“Technological improvement in pharmacist care through systems such as RTPM allows us to make full use of pharmacists’ skills and improve health outcomes.

 

“We commend the SA Government for its commitment to implementing an RTPM system, but will continue to advocate for a nationally-consistent system to enable pharmacists and other healthcare professionals to work together to protect the entire Australian population from medicine-related harm,” Ms Johns said.

 

Media contact:
Carly Lusk
Public Affairs Officer
0487 922 176

Pharmacist-administered flu vaccination age lowered in WA

Wednesday 19 June 2019

 

The Pharmaceutical Society of Australia (PSA) welcomes the move by the Western Australian Government to allow trained pharmacists to administer the flu vaccination to people aged 10 years and over.

 

PSA WA Branch President Dr Fei Sim commended the government’s decision to allow pharmacists to protect more West Australians from the flu.

 

“Allowing trained pharmacists to administer vaccines will significantly increase the immunisation rates within the community.

 

“This is particularly important as confirmed flu cases in WA are already dwarfing those of last year,” Dr Sim said.

 

As of 18 June, the WA Department of Health has advised that there have been 9016 laboratory-confirmed influenza infections in the state and 29 reported deaths. This is in comparison to 1399 confirmed infections and 4 deaths during the same period in 2018.

 

“The administration of vaccines by pharmacists complements the excellent work done by GPs, nurses, Indigenous Health Workers and other immunisers. It increases the immunisation rate and has a positive effect on people’s health in Western Australia,” Dr Sim said.

 

PSA commends the WA Government for making use of pharmacists’ expertise and training to better protect the community against vaccine-preventable diseases.

 

Media contact:
Carly Lusk
Public Affairs Officer
0487 922 176

NSW Budget: PSA calls for expanded roles for pharmacists

Tuesday 18 June 2019

The Pharmaceutical Society of Australia (PSA) welcomes the NSW Government’s Budget commitment to health spending, but calls on the Government to better utilise the skills of pharmacists to improve the state’s healthcare system.

 

PSA NSW Branch President Professor Peter Carroll commended the NSW Government on the addition of 880 allied health staff, including pharmacists. However he said that it is vital that NSW Health looks at the allocation of these positions across various practice settings, not just hospitals.

 

Furthermore, with record numbers of people presenting to NSW emergency departments over the last year, the Budget misses the opportunity to build on the accessibility of community pharmacies in improving consumer access to health services, particularly in regional areas.

 

“Rural and regional Australia deserve better access to health services and medicines.

 

“Community pharmacists are accessible and have the skills and expertise to create better access to medicines and health services, particularly in these regional areas.

 

“There needs to be a focus on models of care outside the hospital system to better service the needs of these communities,” Professor Carroll said.

 

The Budget announcement of a new Ageing and Disability Commissioner is a great step forward. PSA calls on the Commissioner, when elected, to support a greater role for pharmacists in the aged care sector. Pharmacists, as medicine experts, must be involved in the medication management of people living in residential aged care facilities.

 

PSA’s Medicine Safety: Take Care report showed that 98 per cent of residents in a residential aged care facility have at least one medicine-related problem and over half are exposed to at least one potentially inappropriate medicine. Pharmacists are best placed to improve decision making to ensure the safe and optimal use of medicines for older Australians.

 

The funding allocated to palliative care provides a great opportunity for pharmacists to have an expanded role in medicine management for palliative care patients through symptom-based care, anticipatory care and deprescribing.

 

“Embedding pharmacists into palliative care teams will improve decision making and medicine safety. Pharmacists play a vital role in medicines management and this is pertinent to palliative care patients that are managed in the community,” Professor Carroll said.

 

PSA has worked closely with the NSW Clinical Excellence Commission to develop resources and support tools, and create professional development opportunities specific to pharmacists. Now is the perfect time to embed pharmacists within NSW palliative care teams to improve decision making for the safe and appropriate use of medicines throughout all phases of care.

 

Given the Budget surplus, PSA is surprised that no funding has been allocated for a real time prescription monitoring (RTPM) system to help improve the quality use of medicines in NSW.

 

Medicine-related problems cause 250,000 hospital admissions and 400,000 emergency department presentations in Australia each year, costing the healthcare system $1.4 billion annually. At least half of this harm is avoidable.

 

“Medicine safety is a health priority and it is disappointing to see that there is no investment by the NSW Government in a real time prescription monitoring system in NSW, which will aid clinical decision making and provide an opportunity to identify and appropriately manage patients misusing specific prescription medications.

 

“All states, except NSW and WA, have either implemented or set strategies to introduce a real time monitoring system. However NSW continues to fall further behind despite experience internationally and locally that when such systems are implemented they have the desired effect in reducing harm,” Professor Carroll said.

 

PSA will continue to engage with the NSW Government on these issues to help improve healthcare accessibility and optimal health outcomes for all NSW residents.

 

Media contact:   
Carly Lusk
Public Affairs Officer
0487 922 176

Pharmacists recognised in Queen’s Birthday Honours

Monday 10 June 2019

 

The Pharmaceutical Society of Australia (PSA) congratulates the seven pharmacists recognised in today’s Queen’s Birthday Honours announcement – from New South Wales: Mr Warwick Plunkett, Mrs Carlene Smith, Ms Juliet Seifert, Mr David North and Mrs Dianne North; and from Queensland: Emeritus Professor Maree Therese Smith and Ms Catherine Reid.

 

Professor Smith has been honoured as a Companion of the Order of Australia (AC) for eminent service to science through pioneering research and innovation in the treatment of neuropathic pain, to gender equity, and as a role model.

 

PSA National President Dr Chris Freeman said the award acknowledges Professor Smith’s lifetime of service.

 

“Maree has been a member of PSA for 43 years and during this time has made countless contributions to the fields of pharmacy and pain research.

 

“Being bestowed the highest level of honour within the Order of Australia is recognition of the impact her work has had on Australia’s healthcare system.”

 

Mr Plunkett and Mrs Smith have been honoured as Members of the Order of Australia (AM) for significant service to pharmacy, and to professional organisations.

 

Dr Freeman said Mr Plunkett and Mrs Smith’s dedication and commitment to pharmacy practice and the health of their communities makes them highly deserving recipients.

 

“It is pleasing to see Warwick and Carlene’s service to the pharmacy profession and the broader healthcare system recognised at a national level, and for that PSA extends its congratulations.”

 

Mr Plunkett has served as PSA National President, is a current Board Member (since 2007) and a Lifetime Fellow.

 

“Warwick has committed his professional life to pharmacy and advancing the role of pharmacists to maximise patient care.

 

“Whether it be related to policy, education, practice support or advocacy, Warwick has been instrumental in establishing contemporary pharmacy practice ensuring Australians have better access to health and medicines,” Dr Freeman said.

 

Mrs Smith, a Life Member of PSA, provides comprehensive medication reviews for patients, accredited by the Australian Association of Consultancy Pharmacy, and is a Community Pharmacy Consultant. She has also held positions within The Pharmacy Guild of Australia NSW Branch and the University of Sydney.

 

PSA Member Ms Reid is also recognised as a Member of the Order of Australia for significant service to healthcare delivery, and to philanthropy. She is a current co-owner of Epic Pharmacy and co-founder of the Epic Good Foundation. Ms Reid was featured in Australian Pharmacist in December 2018.

 

Ms Seifert has been recognised with the Medal of the Order of Australia (OAM) for service to the pharmaceutical and therapeutic goods industries. She was an Inaugural Member of the Australian Therapeutic Goods Advisory Council and Executive Director of the Australian Self-Medication Industry from 1989-2010.

 

Mr and Mrs North are recipients of the Medal of the Order of Australia (OAM) for service to the community of the Illawarra. They have been honoured for their extensive volunteer work with local service and sporting organisations. Mr North, a PSA member, has worked with PSA to enable professional development opportunities for pharmacists in the Illawarra area. Mrs North has presented at PSA conferences, and is a former recipient of PSA’s Jack Thomas Perpetual Trophy and Excellence in Pharmacy Practice Medal.

 

“I sincerely congratulate all of today’s Queen’s Birthday Honours recipients and thank them for their ongoing service to the pharmacy profession and their local communities,” Dr Freeman said.

 

A full list of the Queen’s Birthday Honours is available on the Governor-General’s website.

 

Media contact:
Carly Lusk
Public Affairs Officer
0487 922 176

PSA welcomes reappointment of Federal Health Minister

26 May 2019

 

The Pharmaceutical Society of Australia (PSA) today welcomes the reappointment of the Hon Greg Hunt MP as Minister for Health.

 

PSA National President Dr Chris Freeman said PSA has an excellent working relationship with Minister Hunt and looks forward to continuing to work with him and the Morrison Government to make full use of pharmacists’ expertise and clinical training improving access to care and medicine safety for all Australians.

 

“PSA welcomed Minister Hunt’s commitment on behalf of the Government that they will declare quality use of medicines and medicines safety a National Health Priority Area. This is a vital step forward in addressing the alarming issue of medicine-related harm.

 

“Pharmacists with their unique expertise in medicines and medicine management are ideally placed to identify and help resolve these issues, and funding arrangements must reflect their skills, training and responsibility in this area. PSA looks forward to working with the Morrison Government on this health priority,” Dr Freeman said.

 

PSA believes in the need to build upon the accessibility of community pharmacy and increased funding for the delivery of health care services such as vaccinations, medication management and minor illness care.

 

“We therefore appreciate the commitment from Minister Hunt that PSA will be a signatory to the upcoming 7th Community Pharmacy Agreement. PSA will be focused on ensuring that there is more funding allocated to expanding services delivered by pharmacists, addressing accessibility to primary healthcare, and improved medicines management. We stand ready to engage with the Government on this vital agreement,” Dr Freeman said.

 

PSA also welcomes the appointment of Senator the Hon Richard Colbeck as Minister for Aged Care and Senior Australians.

 

Dr Freeman acknowledged the Government’s 2019-20 Budget commitment for a Canberra-based trial to embed pharmacists in aged care facilities to improve medication management.

 

“PSA’s Medicine Safety: Take Care report showed that more than 90 per cent of residents in a residential aged care facility have at least one medicine-related problem and as many as 80 per cent are prescribed potentially inappropriate medicines.

 

“There is compelling evidence to support the greater role pharmacists should have in the aged care sector using their unique skills to improve decision making to ensure the safe and optimal use of medicines for older Australians.

 

“PSA looks forward to working with Minister Hunt and Senator Colbeck on this trial, and helping to inform further nationwide initiatives.”

 

Dr Freeman said these commitments, among others, will further unlock the potential of pharmacists and allow them to improve healthcare access and outcomes for Australians, and reduce variabilities in care.

 

“PSA and the pharmacy profession look forward to continuing to work with the Morrison Government on improving the health outcomes of all Australians.”

 

Media contact:
Carly Lusk
Public Affairs Officer
0487 922 176

PSA and the Morrison Government to work together to improve medicine safety

20 May 2019

 

The Pharmaceutical Society of Australia (PSA) today congratulates the re-elected Morrison Government and looks forward to working together to address medicine safety, negotiating the next Community Pharmacy Agreement and delivering better healthcare for all Australians.

 

PSA National President Dr Chris Freeman said pharmacists are among the most accessible health professionals, but they need to be better supported to practise to the full extent of their skills, expertise and training.

 

“PSA’s Pharmacists in 2023 report shows how an evolved healthcare system can empower pharmacists to provide more effective and efficient services. Prior to the election, PSA asked the Government to commit to several actions to make this possible.”

 

In response to pre-election commitment requests from the PSA, the Morrison Government made a number of important commitments to PSA and the pharmacy profession. Minister Hunt, on behalf of the Coalition stated “A re-elected Morrison Government will continue to support the pharmacy profession in meeting community health needs by ensuring that pharmacists are utilised to their full scope of practice”.

 

Importantly, the Morrison Government endorsed PSA’s Pharmacists in 2023 report. “The Morrison Government agrees with the Pharmaceutical Society of Australia’s vision for the pharmacy profession outlined in the Pharmacists in 2023 report. This is in recognition that it will improve outcomes for patients, the profession and for Australia’s health system.”

 

PSA looks forward to progressing fair remuneration for pharmacists in recognition of their professional contribution in supporting people’s health – a key action from our Pharmacists in 2023 report.

 

“Pharmacists are underpaid noting their key role in healthcare. This needs to be addressed as we head into negotiations for the next Community Pharmacy Agreement,” Dr Freeman said.

 

PSA received a commitment from the Coalition to declare medicine safety a National Health Priority Area as requested by the PSA through our Federal Budget Submission and in response to PSA’s Medicine Safety: Take Care report which highlighted that $1.4 billion dollars is lost annually in our healthcare system because of safety issues associated with medicines.

 

In his response on behalf of the Coalition, The Hon Greg Hunt MP, Minister for Health, stated that the Coalition will work through the Council of Australian Governments Health Council, with the Australian Commission of Safety and Quality in Healthcare, PSA and key stakeholders to support the initiation of this priority. This commitment highlights the pivotal role PSA will play in shaping the future of medicine safety in Australia.

 

We also welcome the Coalition’s announcement earlier this year that PSA will be a signatory to the 7th Community Pharmacy Agreement (7CPA). As a signatory to 7CPA, PSA will work to preserve the accessibility of community pharmacy for the delivery of healthcare services such as vaccinations, medication management and minor illness care. We will also ensure that the 7CPA utilises pharmacists to their full scope of practice and has pharmacists delivering services tailored to community needs.

 

PSA will engage with the Government on aligning the incentives for pharmacists to support rural and remote communities with those of other health practitioners. Dr Freeman said that Australians living in rural and remote areas are more likely to have chronic conditions and poorer health outcomes than people in major cities.

 

“Pharmacists could play a much greater role in rural and remote areas, where they are often one of the only health providers. It’s only logical that the incentives for other health professionals should be available to pharmacists as well.

 

“All of these commitments, if fulfilled, will further unlock the potential of pharmacists and allow them to improve healthcare access and outcomes for Australians, and reduce variabilities in care.”

 

PSA offers its commiserations to the Labor Party on the election outcome and looks forward to continuing our constructive relationship with Catherine King and the Labor Party while they remain in Opposition.

 

“PSA looks forward to working closely with the Morrison Government and Minister Hunt, with whom we have an excellent working relationship, to make full use of pharmacists’ expertise and clinical training to improve access to care and medicine safety for all Australians,” Dr Freeman said.

 

Media contact:   
Carly Lusk
Public Affairs Officer
0487 922 176

Major parties commit to addressing medicine safety

May 15, 2019

 

The Coalition, Labor Party and the Greens have all responded to the Pharmaceutical Society of Australia’s (PSA) five election action items, ahead of the federal election – highlighting their support for the valuable role pharmacists play in our healthcare system.

 

Both the Coalition and the Greens have committed to declaring medicine safety a National Health Priority Area. Labor advised that the key role pharmacists play in the supply of medicines is reflected in their National Platform. Their Australian Health Reform Commission would no doubt highlight the issue of medicine safety and the need for investment in quality use of medicines.

 

PSA National President Dr Chris Freeman said this acknowledgement by the major parties is vital step forward in addressing the alarming issue of medicine-related harm.

 

“Medicine-related problems cause 250,000 hospital admissions and 400,000 emergency department presentations in Australia each year, costing the healthcare system $1.4 billion annually. At least half of this harm is avoidable, and pharmacists are the key to improving the safe and quality use of medicines,” Dr Freeman said.

 

Addressing medicine safety is the first of five commitments PSA has sought from an incoming Government:

 

1. Address the alarming rate of medicine-related harm in our health system by declaring medicine safety a National Health Priority Area (NHPA)
2. Provide funding to embed pharmacists within healthcare teams, particularly in residential aged care facilities
3. Accept the MBS Review Taskforce’s recommendations to allow pharmacists to access allied health items to provide medication management services to patients with complex care requirements
4. Align the incentives for pharmacists to support rural and remote communities with those of other rural and remote health practitioners
5. Include PSA as a signatory to the Community Pharmacy Agreement.

 

“To meet community health needs, we must ensure pharmacists can practise to their full potential, develop within a team of health professionals and have a quality agenda for the services and care they deliver,” Dr Freeman said.

 

“PSA looks forward to working closely with an incoming Government to empower pharmacists to do more to deliver better healthcare for all Australians.”

 

Responses from:

 

• The Coalition
• Labor Party
• The Greens

 

Media contact:
Carly Lusk
Public Affairs Officer
0487 922 176

Pharmacist-administered vaccination age lowered in Queensland

Friday 5 April 2019

 

Pharmacists will be able to protect more Queenslanders against vaccine-preventable diseases, the Queensland Government announced today in a move welcomed by the Pharmaceutical Society of Australia (PSA).

 

Pharmacists will be able to vaccinate more people following the Queensland Government’s announcement to lower the minimum age of pharmacist-administered vaccinations to 16 years.

 

PSA Queensland Acting President Mr Chris Campbell congratulated the Government for allowing pharmacists to vaccinate more Queenslanders.

 

“Allowing trained pharmacists to administer vaccines will significantly increase the immunisation rates within the community and reduce the incidence of vaccine-preventable diseases.

 

“The administration of vaccines by pharmacists complements the excellent work done by GPs, nurses, Indigenous Health Workers and other immunisers. It increases the immunisation rate and has a positive effect on people’s health in Queensland.

 

“As the peak national body for pharmacists, PSA has advocated for many years to allow pharmacists to deliver more vaccinations to a wider age range of patients and for provision of pharmacist access to NIP stock. We will continue to work closely with the Queensland Government to achieve this.”

 

Pharmacists in Queensland have been instrumental in progressing pharmacist-administered vaccination services in Australia through the Queensland Pharmacists Immunisation Pilot (QPIP) in 2014.

 

Mr Campbell commended the Queensland Government for making use of pharmacists’ expertise and training to better protect the community against vaccine-preventable diseases.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

Budget’s health funding welcome but more is needed for pharmacy

Tuesday 2 April 2019

 

The government’s commitment to pharmacy in tonight’s 2019-20 Federal Budget through the extension of the AHI fee and reduced Pharmaceutical Benefits Scheme (PBS) wait times is welcomed by the Pharmaceutical Society of Australia (PSA).

 

PSA National President Dr Chris Freeman said PSA acknowledged the investment in primary care, aged care and mental health, and the importance of funding for those sectors.

 

“Leading into the next Community Pharmacy Agreement, we would expect at least the same level of investment in community pharmacy and pharmacists to improve accessibility of care and health outcomes for all Australians,” Dr Freeman said.

 

“In a budget that has now returned to surplus and is projected to be in surplus we need to have investment in pharmacy and pharmacists across sectors to improve the health of Australians.

 

“We note the budget announcement to align community pharmacy and private or public hospital pricing arrangements for high cost medicines but we remain concerned about the level of hospital pharmacy services that may be affected by this announcement and the impact this may have on medicine safety and patient care.

 

“PSA welcomes the government’s announcement of an additional $15 million for pharmacy programs through the sixth Community Pharmacy Agreement to promote quality use of medicines, including further supporting the Dose Administration Aids and MedsCheck programs.

 

“We are delighted the government will build on its efforts to reduce prescription opioid use. We welcome the expansion of the Rural Health Outreach Fund to give people better access to pain management specialist services and train providers to improve prescribing habits.

 

“The announcement of $7.2 million to establish an Australia-first take-home naloxone program is a significant investment in reducing deaths caused by opioids. It is vital for pharmacy to be a key component of this strategy.”

 

Dr Freeman said the establishment of a new unit of clinical pharmacists within the Aged Care Quality and Safety Commission that will work directly with residential aged care providers to educate them around best practice use of medicines will improve medicine safety across the country.

 

“We also welcome the government’s announcement of support for a Canberra trial to embed a part-time pharmacist in all 27 residential care facilities,” Dr Freeman said.

 

“Pharmacists have unique skills in medicines management and are the best placed professionals to ensure better use of medicines, focusing on regulation, education and intervention.

 

“The Budget begins to address PSA’s call in its pre-budget submission for $17 million of seed funding to embed pharmacists in aged care facilities.

 

“PSA has shown in our Medicine Safety report that medicine safety is a major problem in aged care, where 98% of residents are taking a potentially inappropriate medicine.

 

“Pharmacists embedded in aged care facilities can protect residents from the harm caused by overuse and misuse of medicines.

 

“We need a national commitment to ensure pharmacists are used to their full potential to lead a culture of medicine safety in aged care.

 

“The government’s announcement of funding for the continued operation of the My Health Record system is also a welcome investment that will allow people to access and control their medical history and treatments, including vaccinations.

 

“Nine out of 10 Australians already have a My Health Record and pharmacists are playing an important role in ensuring My Health Record delivers the efficiencies and effectiveness in healthcare that it has promised.”

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

National commitment needed to embed pharmacists in residential aged care

Friday 29 March 2019

 

Today’s announcement by the federal government to invest $3.7 million to embed pharmacists in aged care facilities across the ACT will improve medication management and is welcomed by the peak national body for pharmacists, the Pharmaceutical Society of Australia (PSA). However, a national commitment is urgently needed to embed pharmacists in residential aged care facilities across the country.

 

The announcement goes part way to implementing PSA’s pre-budget submission call for $17 million seed funding for a 12-month program to integrate pharmacists in aged care facilities. The program would be designed to ensure appropriate evidence of the economic and clinical benefits was captured and evaluated, while being adaptable to specific aged care facilities.

 

In welcoming the announcement, PSA National President Dr Chris Freeman noted PSA’s Medicine Safety: Take Care report, released in January 2019, showed medicine safety in aged care is a major problem in Australia.

 

“PSA’s Medicine Safety report reveals 98% of residents in aged care facilities have at least one medication-related problem and at least half of residents are exposed to at least one inappropriate medicine,” Dr Freeman said.

 

“Embedding pharmacists in residential aged care facilities improves quality use of medicines and enables greater communication and collaboration between members of the multidisciplinary team. This has already been demonstrated in the ACT in the partnership between the University of Canberra and Goodwin Aged Care Services.

 

“PSA envisages that aged care facilities would have the ability engage a pharmacist from a community pharmacy or externally, based on the specific needs of the facility and skill set of the pharmacist. The role of the pharmacist would be targeted towards medication safety and clinical governance activities building and leading a quality use of medicine culture for aged care.

 

“Pharmacists in aged care facilities are needed to identify, prevent and manage medication-related problems as well as support health professionals and facility staff in the quality use of medicines. For example, pharmacists in aged care have been shown to safely reduce the use of high-risk medicines such as antipsychotics, benzodiazepines and opioids.

 

“We welcome this announcement to support aged care residents in the ACT benefit from the knowledge and skills of pharmacists in improving safety with their medicines. We encourage the government to work towards further roll-out of embedding pharmacists in aged care nationwide, particularly as the benefits of this specific ACT funding become apparent.”

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176